Skip to main content

Table 1 Anthropometric and clinical measurements of study participants at baseline and 12 wk for each treatment group1

From: Dietary fat and not calcium supplementation or dairy product consumption is associated with changes in anthropometrics during a randomized, placebo-controlled energy-restriction trial

 

Dairy (n = 22 )

Calcium (n = 16)

Placebo (n = 23)

Characteristic

Baseline

12 wk

Baseline

12 wk

Baseline

12 wk

Age (y)

25.1 ± 5.3

25.2 ± 4.9

24.2 ± 4.7

Sex, No.(%)

      

Female

18 (82)

14 (88)

18 (78)

Male

4 (18)

2 (13)

5 (22)

Height (cm)

166.9 ± 6.0

164.6 ± 9.0

166.1 ± 7.6

Glucose (mmol/L) 2,3

4.6 ± 0.4

4.6 ± 0.4

4.8 ± 0.4

4.8 ± 0.5

4.8 ± 0.5

4.8 ± 0.4

Insulin (pmol/L) 2

42.5 ± 28.5

33.5 ± 29.0**

41.8 ± 26.2

35.1 ± 21.1**

35.7 ± 14.7

29.9 ± 10.3**

HOMA-IR2,3

1.3 ± 0.9

1.0 ± 0.9**

1.3 ± 0.9

1.1 ± 0.8**

1.1 ± 0.5

0.9 ± 0.3**

Weight (kg)2

79.1 ± 12.1

74.8 ± 10.4**

79.2 ± 12.6

75.8 ± 10.6**

79.7 ± 11.7

76.5 ± 11.2**

BMI2

28. 3 ± 3.0

26.7 ± 2.5**

29.1 ± 2.7

28.1 ± 2.6**

28.8 ± 2.7

27.7 ± 2.8**

LM (%)2

54.5 ± 5.9

57.9 ± 6.6**

58.3 ± 6.6

58.7 ± 7.0**

55.0 ± 5.9

56.9 ± 5.9**

BF (%)2

41.2 ± 5.7

37.7 ± 6.5**

37.6 ± 6.2

36.0 ± 6.7**

40.9 ± 5.2

38.8 ± 5.2**

WC (cm)2,3

88.9 ± 9.6

81.1 ± 8.6**

88.1 ± 9.2

83.3 ± 7.5**

87.4 ± 11.8

82.6 ± 11.3**

  1. 1Data are means ± SD; n = 61 unless otherwise indicated. WC, waist circumference; LM, lean mass. There were no significant differences in baseline anthropometrics or plasma metabolites among treatment groups (ANOVA).
  2. 2Repeated Measures ANOVA to test the effect of time; confirmed with paired sample t-test for significant differences between baseline and 12 wk, *P < 0.01, **P < 0.001, There was no significant effect of time or time x treatment interaction.
  3. 3n = 59.